Select for export Return of the psychedelics: Psilocybin for treatment resistant depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.ajp.2016.08.010 PubMed 27931907 Copy citation Copy BibTeX Unknown journal 2016-08-22 Patra S. Europe PMC Published psilocybin DepressionAddictionBrain Imaging Clinical Trial More
Select for export Psilocybin for treating substance use disorders? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14737175.2016.1220834 PubMed 27684102 Copy citation Copy BibTeX Unknown journal 2016-08-11 de Veen BT, Schellekens AF, Verheij MM, Homberg JR. Europe PMC Published psilocybin DepressionAddictionMechanism of Action Clinical Trial More
Select for export Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(15)00576-3 PubMed 27067625 Copy citation Copy BibTeX Unknown journal 2016-04-04 Mithoefer MC, Grob CS, Brewerton TD. Europe PMC Published psilocybin AnxietyPTSDAddiction Randomized Controlled Trial More
Select for export Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/zeb.2016.1251 PubMed 27002655 Copy citation Copy BibTeX Unknown journal 2016-03-21 Kyzar EJ, Kalueff AV. Europe PMC Published psilocybin DepressionAnxietyPTSD Animal Study More
Select for export Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125316638008 PubMed 27354908 Copy citation Copy BibTeX Unknown journal 2016-03-17 Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Psilocybin shows potential as treatment for depression No abstract availability was recorded for this entry. Details DOI 10.1211/cp.2016.20201222 Copy citation Copy BibTeX Clinical pharmacist 2015-12-31 Authors unavailable OpenAlex Published psilocybin Depression Other More
Select for export The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nicl.2015.08.009 PubMed 26909323 Copy citation Copy BibTeX NeuroImage Clinical 2015-08-21 Kraehenmann R, Schmidt A, Friston K, Preller KH, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin AnxietyBrain ImagingMechanism of Action Other More
Select for export Legal highs: staying on top of the flood of novel psychoactive substances. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125314559539 PubMed 26240749 Copy citation Copy BibTeX Unknown journal 2015-03-31 Baumeister D, Tojo LM, Tracy DK. Europe PMC Published psilocybin AddictionPharmacologyReview Article Review Article More
Select for export Classic hallucinogens in the treatment of addictions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pnpbp.2015.03.002 PubMed 25784600 Copy citation Copy BibTeX Unknown journal 2015-03-13 Bogenschutz MP, Johnson MW. Europe PMC Published psilocybin AddictionMechanism of ActionMystical Experience Meta-Analysis More
Select for export The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(15)30017-1 Copy citation Copy BibTeX European Psychiatry 2015-02-28 Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114568040 PubMed 25670401 Copy citation Copy BibTeX Journal of psychopharmacology (Oxford, England) 2015-02-28 Majić T, Schmidt TT, Gallinat J PubMed Published psilocybin AnxietyAddictionOCD Clinical Trial More
Select for export Can psychedelic compounds play a part in drug dependence therapy? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjp.bp.114.148031 PubMed 25561484 Copy citation Copy BibTeX Unknown journal 2014-12-31 Sessa B, Johnson MW. Europe PMC Published psilocybin General Other More
Select for export EPA-1211 - Role of 5-HT2a and mglu2 as a gpcr heterocomplex in antipsychotic action Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(14)78457-3 Copy citation Copy BibTeX European Psychiatry 2013-12-31 Javier González-Maeso OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Other More
Select for export The Heffter Research Institute: past and hopeful future. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2014.873688 PubMed 24830182 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2013-12-31 Nichols DE. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3109/00952990.2013.811513 PubMed 23968172 Copy citation Copy BibTeX The American Journal of Drug and Alcohol Abuse 2013-08-31 Burdick BV, Adinoff B. Europe PMC Published psilocybin AddictionMystical ExperienceClinical Trial Randomized Controlled Trial More
Select for export Psychedelics and mental health: a population study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0063972 PubMed 23976938 Copy citation Copy BibTeX PLoS ONE 2013-08-18 Krebs TS, Johansen PØ. Europe PMC Published psilocybin DepressionAnxietyPTSD Observational Study More
Select for export PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/jnnp-2013-306103.17 Copy citation Copy BibTeX Journal of Neurology Neurosurgery & Psychiatry 2013-08-05 Robin Carhart-Harris OpenAlex Published psilocybin AnxietyEnd-of-Life DistressBrain Imaging Clinical Trial More
Select for export Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1503/jpn.120128 Copy citation Copy BibTeX Фундаментальные исследования (Fundamental Research) 2013-02-28 Young SN. Europe PMC Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/15733998113099990002 PubMed 23627783 Copy citation Copy BibTeX Unknown journal 2013-02-28 Bogenschutz MP. Europe PMC Published psilocybin AddictionBrain ImagingAging Clinical Trial More
Select for export Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/archgenpsychiatry.2010.116 PubMed 20819978 Copy citation Copy BibTeX Archives of General Psychiatry 2010-09-05 Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL Europe PMC Published psilocybin DepressionAnxietyAging Other More
